Increased levels of serum IL-33 is associated with adverse maternal outcomes in placenta previa accreta

References

• Royal College of Obstetricians and Gynaecologists (RCOG). Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management (Green-top Guideline No 27). London (UK): Royal College of Obstetricians and Gynaecologists. 2011.
   Google Scholar
• Spong CY, Mercer BM, D’alton M, et al. Timing of indicated late-preterm and early-term birth. Obstet Gynecol. 2011;118(2):323–333.
   PubMed Web of Science ®Google Scholar
• Schneiderman M, Balayla J. A comparative study of neonatal outcomes in placenta previa versus cesarean for other indication at term. J Matern Fetal Neonatal Med. 2013;26(11):1121–1127.
   PubMed Web of Science ®Google Scholar
• Committee on Obstetric Practice. ACOG committee opinion. Placenta accreta. Number 266, January 2002. American College of Obstetricians and Gynecologists. Int J Gynecol Obstet. 2002;77(1):77–78.
   PubMedGoogle Scholar
• Publications Committee, Society for Maternal-Fetal Medicine. Placenta accreta. Am J Obstet Gynecol. 2010;203(5):430–439.
   PubMed Web of Science ®Google Scholar
• Umemura K, Ishioka S, Endo T, et al. Roles of microRNA-34a in the pathogenesis of placenta accreta. J Obstet Gynaecol Res. 2013;39(1):67–74.
   PubMed Web of Science ®Google Scholar
• Uyanıkoğlu H, İncebıyık A, Turp AB, et al. Serum angiogenic and anti-angiogenic markers in pregnant women with placenta percreta. Balkan Med J. 2018;35(1):55–60.
   PubMed Web of Science ®Google Scholar
• Bartels HC, Postle JD, Downey P, et al. Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers. Dis Markers. 2018;3:1507674.
   Google Scholar
• Plaisier M. Decidualisation and angiogenesis. Best Pract Res Clin Obstet Gynaecol. 2011;25(3):259–271.
   PubMed Web of Science ®Google Scholar
• Burton GJ, Jauniaux E, Watson AL. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am J Obstet Gynecol. 1999;181(3):718–724.
   PubMed Web of Science ®Google Scholar
• Marcellin L, Delorme P, Bonnet MP, et al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta. Am J Obstet Gynecol. 2018;219(2):193.e1–193.e9.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhou X, Han TL, et al. Decreased IL-33 production contributes to trophoblast cell dysfunction in pregnancies with preeclampsia. Mediators Inflamm. 2018;15:9787239–9787211.
   Google Scholar
• Hu WT, Li MQ, Liu W, et al. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling. Mol Hum Reprod. 2014;20(4):358–372.
   PubMed Web of Science ®Google Scholar
• Jovanović M, Vićovac L. Interleukin-6 stimulates cell migration, invasion and integrin expression in HTR-8/SVneo cell line. Placenta. 2009;30(4):320–328.
   PubMed Web of Science ®Google Scholar
• Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006;107(4):927–941.
   PubMed Web of Science ®Google Scholar
• Committee on Obstetric Practice. Committee Opinion No. 713: Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130(2):e102–e109.
   PubMed Web of Science ®Google Scholar
• Pacheco LD, Saade GR, Costantine MM, et al. An update on the use of massive transfusion protocols in obstetrics. Am J Obstet Gynecol. 2016;214(3):340–344.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Practice Bulletin No. 170: Critical Care in Pregnancy. Obstet Gynecol. 2016;128(4):e147–e154.
   PubMedGoogle Scholar
• Fock V, Mairhofer M, Otti GR, et al. Macrophage-derived IL-33 is a critical factor for placental growth. J Immunol. 2013;191(7):3734–3743.
   PubMed Web of Science ®Google Scholar
• Hu W-T, Huang L-L, Li M-Q, et al. Decidual stromal cell-derived IL-33 contributes to Th2 bias and inhibits decidual NK cell cytotoxicity through NF-κB signaling in human early pregnancy. J Reprod Immunol. 2015;109:52–65.
   PubMed Web of Science ®Google Scholar
• Tong X, Barbour M, Hou K, et al. Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways. Mol Oncol. 2016;10(1):113–125.
   PubMed Web of Science ®Google Scholar
• Mager LF, Riether C, Schürch CM, et al. IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. J Clin Invest. 2015;125(7):2579–2591.
   PubMed Web of Science ®Google Scholar
• Palmer G, Gabay C. Interleukin-33 biology with potential insights into human diseases. Nat Rev Rheumatol. 2011;7(6):321–329.
   PubMed Web of Science ®Google Scholar
• Topping V, Romero R, Than NG, et al. Interleukin-33 in the human placenta. J Matern Fetal Neonatal Med. 2013;26(4):327–338.
   PubMed Web of Science ®Google Scholar
• Beneventi F, Locatelli E, De Amici M, et al. Maternal and fetal leptin and interleukin 33 concentrations in pregnancy complicated by obesity and preeclampsia. J Matern Fetal Neonatal Med. 2019;27:1–7.
   Google Scholar
• Soheilyfar S, Nikyar T, Fathi Maroufi N, et al. Association of IL-10, IL-18, and IL-33 genetic polymorphisms with recurrent pregnancy loss risk in Iranian women. Gynecol Endocrinol. 2019;35(4):342–345.
   PubMed Web of Science ®Google Scholar
• Granne I, Southcombe JH, Snider JV, et al. ST2 and IL-33 in pregnancy and pre-eclampsia. PLoS ONE. 2011;6(9):e24463.
   PubMed Web of Science ®Google Scholar
• He R, Yin H, Yuan B, et al. IL-33 improves wound healing through enhanced M2 macrophage polarization in diabetic mice. Mol Immunol. 2017;90:42–49.
   PubMed Web of Science ®Google Scholar
• Theodoropoulou S, Copland DA, Liu J, et al. Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye. J Pathol. 2017;241(1):45–56.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Davis C, Shah S, et al. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis. Mol Carcinog. 2017;56(1):272–287.
   PubMed Web of Science ®Google Scholar
• Carusi DA. The placenta accreta spectrum: epidemiology and risk factors. Clin Obstet Gynaecol. 2018;61(4):733–742.
   Web of Science ®Google Scholar
• Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta. 2008;29(7):639–645.
   PubMed Web of Science ®Google Scholar